Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes
NCT ID: NCT04974489
Last Updated: 2022-11-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1153 participants
INTERVENTIONAL
2021-07-01
2021-08-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices
NCT04740008
Communicating About Nicotine Reduction in Cigarettes
NCT06787937
Enhancing Source Credibility in Tobacco Regulatory Communications
NCT03339206
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
NCT07116837
Young Adults' Responses to Anti-smoking Messages
NCT01954407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recruitment:
We will enroll participants from an existing nationally representative panel.
Informed Consent:
Potential participants are part of an existing nationally representative panel and have already consented to participate in the panel. Before enrolling, participants will also be asked to consent to participate in this study via a consent form included in the study survey.
Randomization:
Survey software will randomly allocate participants to one of the four arms of the study (3 intervention arms or a control arm). Each study arm will have approximately the same number of participants.
Assessment:
Participants will complete a 15-minute survey. The survey will begin with an introduction to the concept of VLNC cigarettes. Then participants will be shown intervention or control messages, and their beliefs will be assessed.
Detailed Description of the Intervention:
Participants will be shown a set of 3 messages about the harms of VLNC cigarettes (intervention arms) or about littering (control arm). Each of the 3 intervention arms use a different theme to attempt to correct the VLNC misperception.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Emotion-based messages about the harm of VLNC
Emotion-based messages about the harm of VLNC
Participants in this arm will receive 3 emotion-based messages about the harm of VLNC during the survey data collection.
Continued-harm-framed messages about the harm of VLNC
Continued-harm-framed messages about the harm of VLNC
Participants in this arm will receive 3 continued-harm-framed messages about the harm of VLNC during the survey data collection.
Myth-refuting messages about the harm of VLNC
Myth-refuting messages about the harm of VLNC
Participants in this arm will receive 3 myth-refuting messages messages about the harm of VLNC during the survey data collection.
Control messages about littering
Control messages about littering
Participants in this arm will receive 3 control messages about littering during the survey data collection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Emotion-based messages about the harm of VLNC
Participants in this arm will receive 3 emotion-based messages about the harm of VLNC during the survey data collection.
Continued-harm-framed messages about the harm of VLNC
Participants in this arm will receive 3 continued-harm-framed messages about the harm of VLNC during the survey data collection.
Myth-refuting messages about the harm of VLNC
Participants in this arm will receive 3 myth-refuting messages messages about the harm of VLNC during the survey data collection.
Control messages about littering
Participants in this arm will receive 3 control messages about littering during the survey data collection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 or older
* Enrolled in existing nationally representative panel where recruitment is based
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
UNC Lineberger Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
M. Justin Byron, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-1284
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.